627 related articles for article (PubMed ID: 31718319)
21. Coxsackievirus B3-induced chronic myocarditis in mouse: use of whole blood culture to study the activation of TNF alpha-producing cells.
Hober D; Andreoletti L; Shen L; Copin MC; Desmidt A; Wattré P
Microbiol Immunol; 1996; 40(11):837-45. PubMed ID: 8985939
[TBL] [Abstract][Full Text] [Related]
22. Cardiac fibroblasts aggravate viral myocarditis: cell specific coxsackievirus B3 replication.
Lindner D; Li J; Savvatis K; Klingel K; Blankenberg S; Tschöpe C; Westermann D
Mediators Inflamm; 2014; 2014():519528. PubMed ID: 25374444
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of coagulation factor Xa improves myocardial function during CVB3-induced myocarditis.
Malz R; Weithauser A; Tschöpe C; Schultheiss HP; Rauch U
Cardiovasc Ther; 2014 Jun; 32(3):113-9. PubMed ID: 24533719
[TBL] [Abstract][Full Text] [Related]
24. Soluble coxsackie- and adenovirus receptor (sCAR-Fc); a highly efficient compound against laboratory and clinical strains of coxsackie-B-virus.
Pinkert S; Dieringer B; Diedrich S; Zeichhardt H; Kurreck J; Fechner H
Antiviral Res; 2016 Dec; 136():1-8. PubMed ID: 27773751
[TBL] [Abstract][Full Text] [Related]
25. Recombinant Mouse β-Defensin 3 Protects against Coxsackievirus B3-Induced Myocarditis in Mice.
Jiang Y; Zhu R; Luo L; Mu Q; Zhu Y; Luo H; Zou X; Shen X
Intervirology; 2015; 58(6):343-9. PubMed ID: 26829552
[TBL] [Abstract][Full Text] [Related]
26. Proteasome inhibition attenuates coxsackievirus-induced myocardial damage in mice.
Gao G; Zhang J; Si X; Wong J; Cheung C; McManus B; Luo H
Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H401-8. PubMed ID: 18515649
[TBL] [Abstract][Full Text] [Related]
27. IL-22-producing Th22 cells play a protective role in CVB3-induced chronic myocarditis and dilated cardiomyopathy by inhibiting myocardial fibrosis.
Guo Y; Wu W; Cen Z; Li X; Kong Q; Zhou Q
Virol J; 2014 Dec; 11():230. PubMed ID: 25547181
[TBL] [Abstract][Full Text] [Related]
28. Persistent expression of cytokines in the chronic stage of CVB3-induced myocarditis in NMRI mice.
Glück B; Schmidtke M; Merkle I; Stelzner A; Gemsa D
J Mol Cell Cardiol; 2001 Sep; 33(9):1615-26. PubMed ID: 11549341
[TBL] [Abstract][Full Text] [Related]
29. QiHong prevents death in coxsackievirus B3 induced murine myocarditis through inhibition of virus attachment and penetration.
Song X; Liu Z; Wang H; Xin Y; Wang X; Chen J; Shi Y; Zhang C; Hui R
Exp Biol Med (Maywood); 2007 Dec; 232(11):1441-8. PubMed ID: 18040068
[TBL] [Abstract][Full Text] [Related]
30. A phosphorothioate antisense oligodeoxynucleotide specifically inhibits coxsackievirus B3 replication in cardiomyocytes and mouse hearts.
Yuan J; Cheung PK; Zhang H; Chau D; Yanagawa B; Cheung C; Luo H; Wang Y; Suarez A; McManus BM; Yang D
Lab Invest; 2004 Jun; 84(6):703-14. PubMed ID: 15094712
[TBL] [Abstract][Full Text] [Related]
31. NOD2 (Nucleotide-Binding Oligomerization Domain 2) Is a Major Pathogenic Mediator of Coxsackievirus B3-Induced Myocarditis.
Tschöpe C; Müller I; Xia Y; Savvatis K; Pappritz K; Pinkert S; Lassner D; Heimesaat MM; Spillmann F; Miteva K; Bereswill S; Schultheiss HP; Fechner H; Pieske B; Kühl U; Van Linthout S
Circ Heart Fail; 2017 Sep; 10(9):. PubMed ID: 28912259
[TBL] [Abstract][Full Text] [Related]
32. Experimental CVB3-induced chronic myocarditis in two murine strains: evidence of interrelationships between virus replication and myocardial damage in persistent cardiac infection.
Andréoletti L; Hober D; Becquart P; Belaich S; Copin MC; Lambert V; Wattré P
J Med Virol; 1997 Jun; 52(2):206-14. PubMed ID: 9179770
[TBL] [Abstract][Full Text] [Related]
33. Fasudil exerts a cardio-protective effect on mice with coxsackievirus B3-induced acute viral myocarditis.
Dai K; Wang Y; Tai S; Ni H; Lian H; Yu Y; Liao W; Zheng C; Chen Q; Kuver A; Li J
Cardiovasc Ther; 2018 Dec; 36(6):e12477. PubMed ID: 30380183
[TBL] [Abstract][Full Text] [Related]
34. Phyllaemblicin B inhibits Coxsackie virus B3 induced apoptosis and myocarditis.
Wang YF; Wang XY; Ren Z; Qian CW; Li YC; Kaio K; Wang QD; Zhang Y; Zheng LY; Jiang JH; Yang CR; Liu Q; Zhang YJ; Wang YF
Antiviral Res; 2009 Nov; 84(2):150-8. PubMed ID: 19699238
[TBL] [Abstract][Full Text] [Related]
35. Protease-activated receptor-2 regulates the innate immune response to viral infection in a coxsackievirus B3-induced myocarditis.
Weithauser A; Bobbert P; Antoniak S; Böhm A; Rauch BH; Klingel K; Savvatis K; Kroemer HK; Tschope C; Stroux A; Zeichhardt H; Poller W; Mackman N; Schultheiss HP; Rauch U
J Am Coll Cardiol; 2013 Nov; 62(19):1737-45. PubMed ID: 23871888
[TBL] [Abstract][Full Text] [Related]
36. Colchicine aggravates coxsackievirus B3 infection in mice.
Smilde BJ; Woudstra L; Fong Hing G; Wouters D; Zeerleder S; Murk JL; van Ham M; Heymans S; Juffermans LJ; van Rossum AC; Niessen HW; Krijnen PA; Emmens RW
Int J Cardiol; 2016 Aug; 216():58-65. PubMed ID: 27140338
[TBL] [Abstract][Full Text] [Related]
37. Single-Point Mutations within the Coxsackie B Virus Receptor-Binding Site Promote Resistance against Soluble Virus Receptor Traps.
Pinkert S; Kopp A; Brückner V; Fechner H; Beling A
J Virol; 2020 Sep; 94(19):. PubMed ID: 32669334
[TBL] [Abstract][Full Text] [Related]
38. Caboxamycin Inhibits Heart Inflammation in a Coxsackievirus B3-Induced Myocarditis Mouse Model.
Kim HG; Hillman PF; Lee YJ; Jeon HE; Lim BK; Nam SJ
Viruses; 2024 Apr; 16(5):. PubMed ID: 38793559
[TBL] [Abstract][Full Text] [Related]
39. Osteopontin: a fibrosis-related marker molecule in cardiac remodeling of enterovirus myocarditis in the susceptible host.
Szalay G; Sauter M; Haberland M; Zuegel U; Steinmeyer A; Kandolf R; Klingel K
Circ Res; 2009 Apr; 104(7):851-9. PubMed ID: 19246678
[TBL] [Abstract][Full Text] [Related]
40. Secondary heterotypic versus homotypic infection by Coxsackie B group viruses: impact on early and late histopathological lesions and virus genome prominence.
Yu JZ; Wilson JE; Wood SM; Kandolf R; Klingel K; Yang D; McManus BM
Cardiovasc Pathol; 1999; 8(2):93-102. PubMed ID: 10724506
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]